<VariationArchive VariationID="503966" VariationName="NM_004586.3(RPS6KA3):c.593+2_593+5del" VariationType="Deletion" Accession="VCV000503966" Version="6" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-28" DateCreated="2018-04-02" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="495818" VariationID="503966">
      <GeneList>
        <Gene Symbol="RPS6KA3" FullName="ribosomal protein S6 kinase A3" GeneID="6197" HGNC_ID="HGNC:10432" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp22.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="20149911" stop="20267097" display_start="20149911" display_stop="20267097" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="20168028" stop="20284749" display_start="20168028" display_stop="20284749" Strand="-" />
          </Location>
          <OMIM>300075</OMIM>
          <Haploinsufficiency last_evaluated="2022-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RPS6KA3">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RPS6KA3">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004586.3(RPS6KA3):c.593+2_593+5del</Name>
      <CanonicalSPDI>NC_000023.11:20193481:CTTACTT:CTT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp22.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="20193482" stop="20193485" display_start="20193482" display_stop="20193485" variantLength="4" positionVCF="20193481" referenceAlleleVCF="CCTTA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="20211600" stop="20211603" display_start="20211600" display_stop="20211603" variantLength="4" positionVCF="20211599" referenceAlleleVCF="CCTTA" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004586.2" sequenceAccession="NM_004586" sequenceVersion="2" change="c.593+2_593+5delTAAG">
            <Expression>NM_004586.2:c.593+2_593+5delTAAG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.20211603_20211606del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.20211603_20211606del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.20193485_20193488del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.20193485_20193488del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007488.1" sequenceAccession="NG_007488" sequenceVersion="1" change="g.78148_78151del">
            <Expression>NG_007488.1:g.78148_78151del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004586.3" sequenceAccession="NM_004586" sequenceVersion="3" change="c.593+2_593+5del" MANESelect="true">
            <Expression>NM_004586.3:c.593+2_593+5del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658799620" DB="ClinGen" />
        <XRef Type="rs" ID="1555942692" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004586.3(RPS6KA3):c.593+2_593+5del AND not provided" Accession="RCV000598914" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-12-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004586.3(RPS6KA3):c.593+2_593+5del AND multiple conditions" Accession="RCV001854124" Version="3">
        <ClassifiedConditionList TraitSetID="10232">
          <ClassifiedCondition DB="MedGen" ID="C0265252">Coffin-Lowry syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0796225">Intellectual disability, X-linked 19</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-06-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-06-14" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2018-04-02" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16199547</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19888300</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9837815</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="10232" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10895" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 19</ElementValue>
                <XRef Type="MIM" ID="300844" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300075.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300075.0021" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300075.0020" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Intellectual disability, X-linked 19</ElementValue>
                <XRef ID="MONDO:0010447" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">XLID19</ElementValue>
                <XRef Type="MIM" ID="300844" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="22687" />
                <XRef ID="22687" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301520</ID>
                <ID Source="BookShelf">NBK1346</ID>
              </Citation>
              <XRef ID="777" DB="Orphanet" />
              <XRef ID="C0796225" DB="MedGen" />
              <XRef ID="MONDO:0010447" DB="MONDO" />
              <XRef Type="MIM" ID="300844" DB="OMIM" />
            </Trait>
            <Trait ID="823" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">COFFIN-LOWRY SYNDROME, MILD</ElementValue>
                <XRef Type="Allelic variant" ID="300075.0011" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Coffin-Lowry syndrome</ElementValue>
                <XRef ID="Coffin-Lowry+Syndrome/1709" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010561" DB="MONDO" />
                <XRef ID="15182000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation with osteocartilaginous abnormalities</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Coffin syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CLS</ElementValue>
                <XRef Type="MIM" ID="303600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Coffin-Lowry syndrome (CLS) is usually characterized by severe-to-profound intellectual disability in males; less severely impaired individuals have been reported. Neuropsychiatric concerns can include behavioral problems, loss of strength, progressive spasticity or paraplegia, sleep apnea, or stroke. Stimulus-induced drop attacks (SIDAs) in which unexpected tactile or auditory stimuli or excitement triggers a brief collapse but no loss of consciousness are present in approximately 20% of affected individuals. Typically SIDAs begin between mid-childhood and the teens. Characteristic facial features may be more apparent with age. Upper-extremity differences may be subtle and include short, soft, fleshy hands with tapered fingers as well as fleshy forearms. Progressive kyphoscoliosis is one of the most difficult aspects of long-term care. Affected females tend to have intellectual disability in the mild-to-moderate range and may also have the typical facial, hand, and skeletal findings noted in males.</Attribute>
                <XRef ID="NBK1346" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6123" />
                <XRef ID="6123" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301520</ID>
                <ID Source="BookShelf">NBK1346</ID>
              </Citation>
              <XRef ID="192" DB="Orphanet" />
              <XRef ID="C0265252" DB="MedGen" />
              <XRef ID="MONDO:0010561" DB="MONDO" />
              <XRef Type="MIM" ID="303600" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1390274" SubmissionDate="2019-01-29" DateLastUpdated="2018-04-02" DateCreated="2018-04-02">
        <ClinVarSubmissionID localKey="GDX:1869678|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000710268" DateUpdated="2018-04-02" DateCreated="2018-04-02" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-12-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.593+2_593+5delTAAG pathogenic variant in the RPS6KA3 gene destroys the canonical splice donor site in intron 7. It is predicted to cause abnormal gene splicing, either leading to an abnormal message that is subject to nonsense-mediated mRNA decay, or to an abnormal protein product if the message is used for protein translation. Furthermore, the c.593+2_593+5delTAAG variant is not observed in large population cohorts (Lek et al., 2016). Although this pathogenic variant has not been previously reported to our knowledge, its presence is consistent with the diagnosis in this individual.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPS6KA3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004586.2:c.593+2_593+5delTAAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4239766" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="13315319|MedGen:C0265252;C0796225" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002220669" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16199547</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9837815</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19888300</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has been observed in individual(s) with Coffin-Lowry syndrome (Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 503966). This variant is not present in population databases (ExAC no frequency). This sequence change affects a splice site in intron 7 of the RPS6KA3 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in RPS6KA3 are known to be pathogenic (PMID: 9837815, 19888300).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPS6KA3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.20211600_20211603del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265252" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0796225" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1390274" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4239766" TraitType="Disease" MappingType="XRef" MappingValue="C0796225" MappingRef="MedGen">
        <MedGen CUI="C0796225" Name="Intellectual disability, X-linked 19" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4239766" TraitType="Disease" MappingType="XRef" MappingValue="C0265252" MappingRef="MedGen">
        <MedGen CUI="C0265252" Name="Coffin-Lowry syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

